G
157.68
-3.82 (-2.37%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Diagnostics & Research (US) | 混合的 | 看涨 |
| Diagnostics & Research (全球的) | 混合的 | 看涨 | |
| 股票 | Guardant Health, Inc. | 混合的 | 看涨 |
AIStockmoo 评分
0.0
| 分析师共识 | NA |
| 内部交易活动 | 0.0 |
| 价格波动 | -1.5 |
| 技术平均移动指标 | 1.0 |
| 技术振荡指标 | 0.5 |
| 平均 | 0.00 |
|
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals. |
|
| 部门 | Healthcare |
| 行业 | Diagnostics & Research |
| 投资方式 | Mid Growth |
| 内部持股比例 | 4.53% |
| 机构持股比例 | 97.57% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合